Loading content

Dr Ruben Mujica Mota

Senior Lecturer in Health Economics

6078

Research

Research grants

  • 2014 NIHR HTA
    Grant to undertake systematic reviews of health technologies on behalf of the NICE
  • 2014 Medical Research Council
    Newton Fund Grant for Collaborative Exchange with Brazilian Research Institute Fio Cruz, in Rio de Janeiro

Key publications | Publications by category | Publications by year

Publications by category


Journal articles

Crathorne L, Huxley N, Haasova M, Snowsill T, Jones-Hughes T, Hoyle M, Briscoe S, Coelho H, Long H, Medina-Lara A, et al (In Press). The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer-treatment induced anaemia (including review of TA142): a systematic review and economic model. Health Technology Assessment Abstract.  Full text.
Tikhonova IA, Hoyle MW, Snowsill TM, Cooper C, Varley-Campbell JL, Rudin CE, Mujica Mota RE (2017). Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: an Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal. Pharmacoeconomics, 35(3), 363-373. Abstract.  Author URL.
Ble A, Hughes PM, Delgado J, Masoli JA, Bowman K, Zirk-Sadowski J, Mujica Mota RE, Henley WE, Melzer D (2017). Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: a Quasi-Experimental Study. J Gerontol a Biol Sci Med Sci, 72(2), 243-250. Abstract.  Author URL.  Full text.
Huxley N, Jones-Hughes T, Coelho H, Snowsill T, Cooper C, Meng Y, Hyde C, Mújica-Mota R (2015). A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer. Health Technol Assess, 19(2), v-215. Abstract.  Author URL.  Full text.
Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, Campbell J (2015). Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res, 24(4), 909-918. Abstract.  Author URL.  Full text.
Roberts N, Mujica-Mota R, Williams D (2015). The Cost of Improving Hip Replacement Follow-Up in the UK. Musculoskeletal Care, 14(2), 116-120.
Patel A, Pavlou G, Mújica-Mota RE, Toms AD (2015). The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset. Bone Joint J, 97-B(8), 1076-1081. Abstract.  Author URL.
Medina-Lara A, Mujica-Mota RE (2014). Characterizing the unwell-beings in England. QUALITY OF LIFE RESEARCH, 23, 61-61. Author URL.
Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, Campbell J (2014). Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. QUALITY OF LIFE RESEARCH, 23, 62-62. Author URL.
Medina-Lara A, Mujica-Mota RE, Kunkwenzu ED, Lalloo DG (2014). Stated preferences for anti-malarial drug characteristics in Zomba, a malaria endemic area of Malawi. Malar J, 13 Abstract.  Author URL.  Full text.
Mota REM (2013). Cost-effectiveness analysis of early versus late total hip replacement in Italy. Value Health, 16(2), 267-279. Abstract.  Author URL.
Dieppe P, Mújica Mota RE (2013). When should we do joint replacements? Early or late?. Rheumatology (Oxford), 52(10), 1737-1738. Author URL.
Dieppe P, Mújica Mota RE (2013). When should we do joint replacements? Early or late?: Are data from the West applicable to the developing world?. Rheumatology (United Kingdom), 52(10), 1737-1738.
Medina-Lara A (2012). Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. PLoS One Full text.
Mota REM, Tarricone R, Ciani O, Bridges JFP, Drummond M (2012). Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Serv Res, 12 Abstract.  Author URL.  Full text.
Medina-Lara A, Mujica Mota, Kunkwenzu, Lalloo (2009). Health seeking behaviour after fever onset in a malaria endemic area of Malawi. Am J Trop Med Hyg, 6(81), 935-943.
McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill R, Jones A, Mujica Mota R, Walley T, et al (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technology Assessment, 11(28).
Hill R, Boland A, Dickson R, Dündar Y, Haycox A, McLeod C, Mujica Mota R, Walley T, Bagust A (2007). Drug-eluting stents: a systematic review and economic evaluation. Health Technology Assessment, 11(46).
Haycox A, Mujica Mota RE, Featherstone R (2007). Evaluating the cost effectiveness of asthma inhaler systems: an observational study of patients in General Practice in the UK. Journal of Medical Economics, 10(3), 297-308.
Whiting P, Gupta R, Burch J, Mujica Mota R, Wright K, Marson A, Weishmann U, Haycox A, Kleijnen J, Forbes C, et al (2006). A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. Health Technology Assessment, 10(4).
Mujica Mota R, Lorgelly PK, Mugford M, Toroyan T, Oakley A, Laing G, Roberts I (2006). Out-of-home day care for families living in a disadvantaged area of London: economic evaluation alongside a RCT. Child: Care, Health and Development, 32(3), 287-302.
Wiggins M (2005). Postnatal support for mothers living in disadvantaged inner city areas: a randomised controlled trial. Journal of Epidemiology & Community Health, 59(4), 288-295.
Hill R, Bagust A, Bakhai A, Dickson R, Dündar Y, Haycox A, Mujica Mota R, Reaney A, Roberts D, Williamson P, et al (2004). Coronary artery stents: a rapid systematic review and economic evaluation. Health Technology Assessment, 8(35).
Wiggins M, Oakley A, Roberts I, Turner H, Rajan L, Austerberry H, Mujica R, Mugford M (2004). The Social Support and Family Health Study: a randomised controlled trial and economic evaluation of two alternative forms of postnatal support for mothers living in disadvantaged inner-city areas. Health Technology Assessment, 8(32).
Boland A, Dundar Y, Bagust A, Haycox A, Hill R, Mujica Mota R, Walley T, Dickson R (2003). Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technology Assessment, 7(15).

Chapters

Medina-Lara A, Mujica-Mota R, Hughes D, Mujica Mota RE (2004). Approaches to pharmacoeconomic analysis. In Walley T, Haycox A, Boland A (Eds.) Phramacoeconomics, London: Churchill Livingstone, 101-126.

Conferences

Haasova M, Jones-Hughes T, Peters J, Snowsill T, Coelho H, Crathorne L, Mujica Mota R, Varley-Campbell J, Huxley N, Moore J, et al (2016). Immunosuppressive therapy for renal transplantation in adults: a systematic review and network meta-analyses. Health Technology
Assessment international (HTAi). 10th - 14th May 2016. Abstract.

Reports

Haasova M, snowsill T, jones-hughes T, crathorne L, cooper C, varley-campbell J, mujica mota R, coelho H, huxley N, lowe J, et al (In Press). Immunosuppressive therapy for kidney transplantation in children and adolescents (review of technology appraisal 99); a systematic review and economic evaluation. , NIHR Health Technology Assessment Programme. Abstract.
Mujica-mota R, Varley-Campbell J, Tikhonova I, Cooper C, Hoyle MW, Rudin C, Rule S, Snowsill T (2016). Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts: a Single Technology Appraisal. Author URL.  Full text.
Crathorne L, Huxley N, Haasova M, Snowsill T, Jones-Hughes T, Hoyle M, Briscoe S, Coelho H, Long L, Medina-Lara A, et al (2014). The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142). Author URL.

Publications by year


In Press

Haasova M, snowsill T, jones-hughes T, crathorne L, cooper C, varley-campbell J, mujica mota R, coelho H, huxley N, lowe J, et al (In Press). Immunosuppressive therapy for kidney transplantation in children and adolescents (review of technology appraisal 99); a systematic review and economic evaluation. , NIHR Health Technology Assessment Programme. Abstract.
Crathorne L, Huxley N, Haasova M, Snowsill T, Jones-Hughes T, Hoyle M, Briscoe S, Coelho H, Long H, Medina-Lara A, et al (In Press). The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer-treatment induced anaemia (including review of TA142): a systematic review and economic model. Health Technology Assessment Abstract.  Full text.

2017

Tikhonova IA, Hoyle MW, Snowsill TM, Cooper C, Varley-Campbell JL, Rudin CE, Mujica Mota RE (2017). Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: an Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal. Pharmacoeconomics, 35(3), 363-373. Abstract.  Author URL.
Ble A, Hughes PM, Delgado J, Masoli JA, Bowman K, Zirk-Sadowski J, Mujica Mota RE, Henley WE, Melzer D (2017). Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: a Quasi-Experimental Study. J Gerontol a Biol Sci Med Sci, 72(2), 243-250. Abstract.  Author URL.  Full text.

2016

Mujica-mota R, Varley-Campbell J, Tikhonova I, Cooper C, Hoyle MW, Rudin C, Rule S, Snowsill T (2016). Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts: a Single Technology Appraisal. Author URL.  Full text.
Haasova M, Jones-Hughes T, Peters J, Snowsill T, Coelho H, Crathorne L, Mujica Mota R, Varley-Campbell J, Huxley N, Moore J, et al (2016). Immunosuppressive therapy for renal transplantation in adults: a systematic review and network meta-analyses. Health Technology
Assessment international (HTAi). 10th - 14th May 2016. Abstract.

2015

Huxley N, Jones-Hughes T, Coelho H, Snowsill T, Cooper C, Meng Y, Hyde C, Mújica-Mota R (2015). A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer. Health Technol Assess, 19(2), v-215. Abstract.  Author URL.  Full text.
Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, Campbell J (2015). Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. Qual Life Res, 24(4), 909-918. Abstract.  Author URL.  Full text.
Roberts N, Mujica-Mota R, Williams D (2015). The Cost of Improving Hip Replacement Follow-Up in the UK. Musculoskeletal Care, 14(2), 116-120.
Patel A, Pavlou G, Mújica-Mota RE, Toms AD (2015). The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset. Bone Joint J, 97-B(8), 1076-1081. Abstract.  Author URL.

2014

Medina-Lara A, Mujica-Mota RE (2014). Characterizing the unwell-beings in England. QUALITY OF LIFE RESEARCH, 23, 61-61. Author URL.
Mujica-Mota RE, Roberts M, Abel G, Elliott M, Lyratzopoulos G, Roland M, Campbell J (2014). Common patterns of morbidity and multi-morbidity and their impact on health-related quality of life: evidence from a national survey. QUALITY OF LIFE RESEARCH, 23, 62-62. Author URL.
Medina-Lara A, Mujica-Mota RE, Kunkwenzu ED, Lalloo DG (2014). Stated preferences for anti-malarial drug characteristics in Zomba, a malaria endemic area of Malawi. Malar J, 13 Abstract.  Author URL.  Full text.
Crathorne L, Huxley N, Haasova M, Snowsill T, Jones-Hughes T, Hoyle M, Briscoe S, Coelho H, Long L, Medina-Lara A, et al (2014). The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142). Author URL.

2013

Mota REM (2013). Cost-effectiveness analysis of early versus late total hip replacement in Italy. Value Health, 16(2), 267-279. Abstract.  Author URL.
Dieppe P, Mújica Mota RE (2013). When should we do joint replacements? Early or late?. Rheumatology (Oxford), 52(10), 1737-1738. Author URL.
Dieppe P, Mújica Mota RE (2013). When should we do joint replacements? Early or late?: Are data from the West applicable to the developing world?. Rheumatology (United Kingdom), 52(10), 1737-1738.

2012

Medina-Lara A (2012). Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. PLoS One Full text.
Mota REM, Tarricone R, Ciani O, Bridges JFP, Drummond M (2012). Determinants of demand for total hip and knee arthroplasty: a systematic literature review. BMC Health Serv Res, 12 Abstract.  Author URL.  Full text.

2009

Medina-Lara A, Mujica Mota, Kunkwenzu, Lalloo (2009). Health seeking behaviour after fever onset in a malaria endemic area of Malawi. Am J Trop Med Hyg, 6(81), 935-943.

2007

McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill R, Jones A, Mujica Mota R, Walley T, et al (2007). Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technology Assessment, 11(28).
Hill R, Boland A, Dickson R, Dündar Y, Haycox A, McLeod C, Mujica Mota R, Walley T, Bagust A (2007). Drug-eluting stents: a systematic review and economic evaluation. Health Technology Assessment, 11(46).
Haycox A, Mujica Mota RE, Featherstone R (2007). Evaluating the cost effectiveness of asthma inhaler systems: an observational study of patients in General Practice in the UK. Journal of Medical Economics, 10(3), 297-308.

2006

Whiting P, Gupta R, Burch J, Mujica Mota R, Wright K, Marson A, Weishmann U, Haycox A, Kleijnen J, Forbes C, et al (2006). A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. Health Technology Assessment, 10(4).
Mujica Mota R, Lorgelly PK, Mugford M, Toroyan T, Oakley A, Laing G, Roberts I (2006). Out-of-home day care for families living in a disadvantaged area of London: economic evaluation alongside a RCT. Child: Care, Health and Development, 32(3), 287-302.

2005

Wiggins M (2005). Postnatal support for mothers living in disadvantaged inner city areas: a randomised controlled trial. Journal of Epidemiology & Community Health, 59(4), 288-295.

2004

Medina-Lara A, Mujica-Mota R, Hughes D, Mujica Mota RE (2004). Approaches to pharmacoeconomic analysis. In Walley T, Haycox A, Boland A (Eds.) Phramacoeconomics, London: Churchill Livingstone, 101-126.
Hill R, Bagust A, Bakhai A, Dickson R, Dündar Y, Haycox A, Mujica Mota R, Reaney A, Roberts D, Williamson P, et al (2004). Coronary artery stents: a rapid systematic review and economic evaluation. Health Technology Assessment, 8(35).
Wiggins M, Oakley A, Roberts I, Turner H, Rajan L, Austerberry H, Mujica R, Mugford M (2004). The Social Support and Family Health Study: a randomised controlled trial and economic evaluation of two alternative forms of postnatal support for mothers living in disadvantaged inner-city areas. Health Technology Assessment, 8(32).

2003

Boland A, Dundar Y, Bagust A, Haycox A, Hill R, Mujica Mota R, Walley T, Dickson R (2003). Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technology Assessment, 7(15).

Back | Edit Profile